M Goudemand

1.2k total citations
91 papers, 914 citations indexed

About

M Goudemand is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, M Goudemand has authored 91 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 19 papers in Genetics and 11 papers in Surgery. Recurrent topics in M Goudemand's work include Platelet Disorders and Treatments (26 papers), Blood groups and transfusion (15 papers) and Hemophilia Treatment and Research (14 papers). M Goudemand is often cited by papers focused on Platelet Disorders and Treatments (26 papers), Blood groups and transfusion (15 papers) and Hemophilia Treatment and Research (14 papers). M Goudemand collaborates with scholars based in France, Switzerland and Netherlands. M Goudemand's co-authors include Claudine Mazurier, A Parquet-Gernez, Sylvie Jorieux, Christine Gaucher, J Delobel, J Diéval, Thierry Burnouf, Jean Montreuil, J.J. Huart and Jenny Goudemand and has published in prestigious journals such as Blood, Cancer and FEBS Letters.

In The Last Decade

M Goudemand

79 papers receiving 837 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Goudemand France 18 713 154 128 125 120 91 914
J Akatsuka Japan 14 403 0.6× 74 0.5× 109 0.9× 75 0.6× 86 0.7× 43 734
RF Zwaal Netherlands 9 425 0.6× 129 0.8× 292 2.3× 72 0.6× 38 0.3× 10 779
C. Wasastjerna Finland 13 157 0.2× 98 0.6× 128 1.0× 48 0.4× 50 0.4× 48 500
MC Cañizo Spain 16 947 1.3× 346 2.2× 284 2.2× 38 0.3× 78 0.7× 26 1.2k
Anne M. Sproul United Kingdom 11 326 0.5× 107 0.7× 103 0.8× 24 0.2× 43 0.4× 20 531
Kunitake Hirashima Japan 14 410 0.6× 113 0.7× 218 1.7× 23 0.2× 114 0.9× 44 698
J.Y. Borg France 13 321 0.5× 63 0.4× 124 1.0× 119 1.0× 56 0.5× 20 567
Henderson Es United States 15 293 0.4× 155 1.0× 157 1.2× 29 0.2× 34 0.3× 29 693
S Gentili Italy 10 399 0.6× 345 2.2× 154 1.2× 24 0.2× 53 0.4× 16 685
Letícia Ribeiro Portugal 17 261 0.4× 290 1.9× 212 1.7× 51 0.4× 85 0.7× 58 791

Countries citing papers authored by M Goudemand

Since Specialization
Citations

This map shows the geographic impact of M Goudemand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Goudemand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Goudemand more than expected).

Fields of papers citing papers by M Goudemand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Goudemand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Goudemand. The network helps show where M Goudemand may publish in the future.

Co-authorship network of co-authors of M Goudemand

This figure shows the co-authorship network connecting the top 25 collaborators of M Goudemand. A scholar is included among the top collaborators of M Goudemand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Goudemand. M Goudemand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mazurier, Claudine, Christine Gaucher, Sylvie Jorieux, & M Goudemand. (1994). Biological effect of desmopressin in eight patients with type 2n (‘Normandy’) von Willebrand disease. British Journal of Haematology. 88(4). 849–854. 60 indexed citations
2.
Goudemand, Jenny, et al.. (1992). Clinical and biological evaluation in von Willebrand's disease of a von Willebrand factor concentrate with low factor VIII activity. British Journal of Haematology. 80(2). 214–221. 39 indexed citations
3.
Mazurier, Claudine, et al.. (1991). In vitro Evaluation of a Very‐High‐Purity, Solvent/Detergent‐Treated, Von Willebrand Factor Concentrate. Vox Sanguinis. 61(1). 1–7. 23 indexed citations
4.
Burnouf, Thierry, J.J. Huart, & M Goudemand. (1991). A Highly Purified Factor VIII:c Concentrate Prepared from Cryoprecipitate by Ion‐Exchange Chromatography. Vox Sanguinis. 60(1). 8–15. 51 indexed citations
5.
Mazurier, Claudine, Christine Gaucher, Sylvie Jorieux, A Parquet-Gernez, & M Goudemand. (1990). Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling. British Journal of Haematology. 76(3). 372–379. 56 indexed citations
6.
Mazurier, Claudine, A Parquet-Gernez, & M Goudemand. (1990). Validation of a Procedure for Potency Assessing of a High Purity Factor VIII Concentrate -Comparison of Different Factor VIII Coagulant Assays and Effect of Prediluent. Thrombosis and Haemostasis. 64(2). 251–255. 12 indexed citations
7.
Wajcman, Henri, J. Kister, M.C. Marden, et al.. (1990). Hemoglobin calais [β 76 (E20) Ala → pro]: a hemoglobin variant with decreased intrinsic oxygen affinity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1096(1). 60–66. 8 indexed citations
8.
Michalski, Jean‐Claude, Claudine Mazurier, M Goudemand, et al.. (1989). Primary structure of the majorO-glycosidically linked carbohydrate unit of human von Willebrand factor. Glycoconjugate Journal. 6(3). 263–270. 35 indexed citations
9.
Mazurier, Claudine, Christophe de Romeuf, A Parquet-Gernez, & M Goudemand. (1989). In vitro and in vivo characterization of a high‐purity, solvent/detergent‐treated factor VIII concentrate: Evidence for its therapeutic efficacy in von Willebrand's disease. European Journal Of Haematology. 43(1). 7–14. 19 indexed citations
10.
Mazurier, Claudine, et al.. (1988). Investigation of a large kindred with type IIB von Willebrand's disease, dominant inheritance and age‐dependent thrombocytopenia. British Journal of Haematology. 69(4). 499–505. 12 indexed citations
11.
Mazurier, Claudine, et al.. (1983). Etude comparative de trois techniques de dosage de la fibronectine plasmatiqueRésultats chez le sujet normal. Revue Franç aise de Transfusion et Immuno-hé matologie. 26(2). 135–145. 9 indexed citations
12.
Parquet-Gernez, A, et al.. (1981). Etude des marqueurs sériques et biologiques des hépatites viralesChez 157 hémophiles. Revue Franç aise de Transfusion et Immuno-hé matologie. 24(5). 463–482. 3 indexed citations
13.
Mazurier, Claudine, et al.. (1979). [Factor VIII-related antigen (F VIII R : Ag). Purification by immuno-affinity chromatography].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 288(18). 1431–4. 1 indexed citations
14.
Bauters, F, et al.. (1978). [Specific ovarian localizations in acute leukemias (apropos of 3 cases)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 23(3). 151–7. 1 indexed citations
15.
Goudemand, Jenny, et al.. (1976). [Acute agranulocytosis induced by pyramidon or phenothiazines. Apropos of 31 cases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 52(25-28). 1513–20. 3 indexed citations
16.
Goudemand, M, et al.. (1976). [Australia antigen and hepatitis B].. PubMed. 21(1). 74–83. 1 indexed citations
17.
Bauters, F, et al.. (1975). [Cardiac insufficiency caused by the use of daunorubicin. Clinical and developmental study of 4 recent cases].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 51(28). 1949–57. 1 indexed citations
18.
Goudemand, M, et al.. (1969). [Treatment of acute myeloblastic leukemia by rubidomycin. Statistics on 35 cases].. PubMed. 14(3). 257–63. 4 indexed citations
19.
Goudemand, M, et al.. (1968). [Intestinal angioma with arteriovenous fistula in Rendu-Osler disease, (Diagnosis by selective mesenteric arteriography)].. PubMed. 76(4). 173–4. 2 indexed citations
20.
Goudemand, M, et al.. (1954). [Initial results from the use of actinomycin C in therapy].. PubMed. 62(35). 739–40. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Akatsuka Breakdown of academic impact, for papers by RF Zwaal Breakdown of academic impact, for papers by C. Wasastjerna Breakdown of academic impact, for papers by MC Cañizo Breakdown of academic impact, for papers by Anne M. Sproul Breakdown of academic impact, for papers by Kunitake Hirashima Breakdown of academic impact, for papers by J.Y. Borg Breakdown of academic impact, for papers by Henderson Es Breakdown of academic impact, for papers by S Gentili Breakdown of academic impact, for papers by Letícia Ribeiro
Rankless by CCL
2026